DocTrials Walman Eye Center — Sun City, Arizona

DocTrials Walman Eye Center is a clinical research site located in Sun City, Arizona, United States 85351-3019.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

DocTrials Walman Eye Center has participated in 1 clinical trials.

Therapeutic areas: Glaucoma and Ocular Hypertension.

Sponsors: Santen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sun City

Browse all research sites in Arizona · View every site in Sun City

• Banner Sun Health Research Institute
• Sun Health Research Institute
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Banner Boswell Medical Center
• Arizona Arthritis & Rheumatology Research PLLC
• GI Alliance Sun City
• Barnet Dulaney Perkins Eye Center
• GI Alliance Arizona Digestive Health-Sun City
• Walman Eye Center
• Arizona Arthritis & Rheumatology Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DocTrials Walman Eye Center?

DocTrials Walman Eye Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DocTrials Walman Eye Center conducted?

DocTrials Walman Eye Center has 1 clinical trials on record. Their work covers Glaucoma and Ocular Hypertension.

Is DocTrials Walman Eye Center accredited by Crixeo Clinical Trials?

DocTrials Walman Eye Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DocTrials Walman Eye Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.